Haoqing Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Haoqing Wang has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Brian K. Kobilka
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
4 shared publications - Pamela J. Bjorkman
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
4 shared publications - Zhi Yang
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA
3 shared publications - Jay P. McLaughlin
Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, USA
2 shared publications - Kevin Appourchaux
Washington University in St. Louis
2 shared publications - Michael T. Lerch
Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA
2 shared publications
Latest Publications
- Top Cited Papers
- 18 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6804) , 1274-1281
Protein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase
Defense-associated reverse transcriptases (DRTs) are widespread bacterial antiphage systems that use unconventional mechanisms of polynucleotide synthesis. We show that DRT3, which comprises two distinct RTs (Drt3a and Drt3b) and a noncoding RNA (ncRNA), synthesizes alternating poly(GT/AC) double-stranded DNA. Cryo–electron microscopy structures at 2.6-angstrom resolution reveal a D3-symmetric 6:6:6 complex of Drt3a, Drt3b, and ncRNA. Drt3a produces the poly(GT) strand using a conserved ACACAC template within the ncRNA. Notably, Drt3b synthesizes a complementary, protein-primed poly(AC) strand in the complete absence of a nucleic acid template, using conserved active site residues specific to Drt3b to enforce precise base alternation. These findings expand the functional landscape of nucleic acid polymerases, revealing a protein-templated mechanism for sequence-specific DNA synthesis.
- 18 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 392 (6804) , 1274-1281
Top Cited PapersProtein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase
Defense-associated reverse transcriptases (DRTs) are widespread bacterial antiphage systems that use unconventional mechanisms of polynucleotide synthesis. We show that DRT3, which comprises two distinct RTs (Drt3a and Drt3b) and a noncoding RNA (ncRNA), synthesizes alternating poly(GT/AC) double-stranded DNA. Cryo–electron microscopy structures at 2.6-angstrom resolution reveal a D3-symmetric 6:6:6 complex of Drt3a, Drt3b, and ncRNA. Drt3a produces the poly(GT) strand using a conserved ACACAC template within the ncRNA. Notably, Drt3b synthesizes a complementary, protein-primed poly(AC) strand in the complete absence of a nucleic acid template, using conserved active site residues specific to Drt3b to enforce precise base alternation. These findings expand the functional landscape of nucleic acid polymerases, revealing a protein-templated mechanism for sequence-specific DNA synthesis.
- Open Access
A biased allosteric modulator functions as a molecular glue to induce β 2 AR dimerization
Summary: Family A G-protein coupled receptors (GPCRs) are typically described as monomers, yet growing evidence suggests they can form dimers with distinct signaling properties 1–3 . The mechanisms and therapeutic potential of such dimerization, however, remain poorly understood. Here, we show that AP-7-168, an optimized derivative of a β-arrestin-biased negative allosteric modulator of the β 2 -adrenergic receptor (β 2 AR) that sustains bronchorelaxation in cell and tissue models 4 , functions as a molecular glue to promote β 2 AR homodimerization. Cryo-EM structures reveal a unique binding mode in which two AP-7-168 molecules pack within a pocket formed by transmembrane helices 3, 4, and 5 of two protomers, stabilizing a dimeric conformation that selectively prevents β-arrestin coupling. In cells, AP-7-168 robustly induces β 2 AR dimerization and drives enlarged nanocluster formation. Combined with extensive functional studies, our findings unveil a novel allosteric mechanism by which a small molecule biases β 2 AR signaling through dimerization, highlighting ligand-induced dimerization as a strategy for GPCR modulation.
Open AccessA biased allosteric modulator functions as a molecular glue to induce β 2 AR dimerization
Summary: Family A G-protein coupled receptors (GPCRs) are typically described as monomers, yet growing evidence suggests they can form dimers with distinct signaling properties 1–3 . The mechanisms and therapeutic potential of such dimerization, however, remain poorly understood. Here, we show that AP-7-168, an optimized derivative of a β-arrestin-biased negative allosteric modulator of the β 2 -adrenergic receptor (β 2 AR) that sustains bronchorelaxation in cell and tissue models 4 , functions as a molecular glue to promote β 2 AR homodimerization. Cryo-EM structures reveal a unique binding mode in which two AP-7-168 molecules pack within a pocket formed by transmembrane helices 3, 4, and 5 of two protomers, stabilizing a dimeric conformation that selectively prevents β-arrestin coupling. In cells, AP-7-168 robustly induces β 2 AR dimerization and drives enlarged nanocluster formation. Combined with extensive functional studies, our findings unveil a novel allosteric mechanism by which a small molecule biases β 2 AR signaling through dimerization, highlighting ligand-induced dimerization as a strategy for GPCR modulation.
- Open Access
- 8 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110694
Functional dissection of the zDHHC palmitoyltransferase 5–golgin A7 palmitoylation complex
- 8 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (10) , 110694
Open AccessFunctional dissection of the zDHHC palmitoyltransferase 5–golgin A7 palmitoylation complex
- Top Cited PapersOpen Access
- 21 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (12) , eadq3971
Structure and dynamics determine G protein coupling specificity at a class A GPCR
G protein–coupled receptors (GPCRs) exhibit varying degrees of selectivity for different G protein isoforms. Despite the abundant structures of GPCR–G protein complexes, little is known about the mechanism of G protein coupling specificity. The β 2 -adrenergic receptor is an example of GPCR with high selectivity for Gαs, the stimulatory G protein for adenylyl cyclase, and much weaker for the Gαi family of G proteins inhibiting adenylyl cyclase. By developing a Gαi-biased agonist (LM189), we provide structural and biophysical evidence supporting that distinct conformations at ICL2 and TM6 are required for coupling of the different G protein subtypes Gαs and Gαi. These results deepen our understanding of G protein specificity and bias and can accelerate the design of ligands that select for preferred signaling pathways.
- 21 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (12) , eadq3971
Top Cited PapersOpen AccessStructure and dynamics determine G protein coupling specificity at a class A GPCR
G protein–coupled receptors (GPCRs) exhibit varying degrees of selectivity for different G protein isoforms. Despite the abundant structures of GPCR–G protein complexes, little is known about the mechanism of G protein coupling specificity. The β 2 -adrenergic receptor is an example of GPCR with high selectivity for Gαs, the stimulatory G protein for adenylyl cyclase, and much weaker for the Gαi family of G proteins inhibiting adenylyl cyclase. By developing a Gαi-biased agonist (LM189), we provide structural and biophysical evidence supporting that distinct conformations at ICL2 and TM6 are required for coupling of the different G protein subtypes Gαs and Gαi. These results deepen our understanding of G protein specificity and bias and can accelerate the design of ligands that select for preferred signaling pathways.
- Open Access
Negative allosteric modulation of the µ-opioid receptor
The µ-opioid receptor (µOR) is a well-established target for analgesia, yet conventional opioid receptor agonists cause serious adverse effects, notably addiction and respiratory depression, which have led to the present opioid overdose epidemic. µOR negative allosteric modulators (NAMs) may serve as powerful tools in preventing opioid overdose deaths, but promising chemical scaffolds remain elusive. We screened a large DNA-encoded chemical library against inactive µOR, counter-screening with active, G-protein and agonist bound receptor to “steer” selections toward functional negative allosteric modulators. We discovered a NAM compound with high and selective enrichment to inactive µOR; the molecule potently blocks the activity of orthosteric agonists and enhances the affinity of the key opioid overdose reversal molecule, naloxone. It accomplishes this by binding to a site on the extracellular vestibule proximal to naloxone, stabilizing a unique inactive conformation of the extracellular portions of the second and seventh transmembrane helices. The NAM perturbs orthosteric ligand kinetics in therapeutically desirable ways and works cooperatively with low doses of naloxone in vivo to inhibit morphine-induced antinociception, respiratory depression and conditioned place preference while minimizing withdrawal behaviors. Our results provide detailed structural insights into the mechanism of a negative allosteric modulator for the µOR and demonstrate how it can be exploited in vivo .
Open AccessNegative allosteric modulation of the µ-opioid receptor
The µ-opioid receptor (µOR) is a well-established target for analgesia, yet conventional opioid receptor agonists cause serious adverse effects, notably addiction and respiratory depression, which have led to the present opioid overdose epidemic. µOR negative allosteric modulators (NAMs) may serve as powerful tools in preventing opioid overdose deaths, but promising chemical scaffolds remain elusive. We screened a large DNA-encoded chemical library against inactive µOR, counter-screening with active, G-protein and agonist bound receptor to “steer” selections toward functional negative allosteric modulators. We discovered a NAM compound with high and selective enrichment to inactive µOR; the molecule potently blocks the activity of orthosteric agonists and enhances the affinity of the key opioid overdose reversal molecule, naloxone. It accomplishes this by binding to a site on the extracellular vestibule proximal to naloxone, stabilizing a unique inactive conformation of the extracellular portions of the second and seventh transmembrane helices. The NAM perturbs orthosteric ligand kinetics in therapeutically desirable ways and works cooperatively with low doses of naloxone in vivo to inhibit morphine-induced antinociception, respiratory depression and conditioned place preference while minimizing withdrawal behaviors. Our results provide detailed structural insights into the mechanism of a negative allosteric modulator for the µOR and demonstrate how it can be exploited in vivo .
- Open Access
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 538
Structure based approaches on fentanyl template to design novel mu opioid modulators
ID 52769 Poster Board 538 Opioids are used for the treatment of acute to severe pain. Usage of opioids also produces liabilities like respiratory depression and addiction, which in combination with illicit use of fentanyl and designer analogs has contributed to the opioid epidemic. Most approaches to design safer opioids have been restricted to targeting the orthosteric binding sites. We have recently reported a novel strategy to design functionally selective opioids by targeting the sodium binding allosteric site in the mu opioid receptor (MOR). The lead ligand C6 guano engages a key residue Asp2.50 in the sodium site through a salt bridge with a guanidine group in the ligand. C6 guano shows MOR dependent antinociception with reduced adverse effects seen with clinically used opioids (Faouzi et al., Nature 2023, 613, 767–774). While representing a significant advance in the design of opioids, C6 guano is supraspinally active because of the polar and charged guanidine group. Using the cryo-EM structure of C6 guano bound to MOR, we designed second generation analogs to optimize the systemic activity of C6 guano. Characterization of analogs led to the identification of a fentanyl-derived compound named RO-76 which in TRUPATH assays showed reduced efficacy at all Gi/o/z subtypes and no measurable efficacy at β-arrestin-1/2 and labelled unique transducers in APEX2 proximity labeling assays. Unlike C6 guano which showed direct engagement of the sodium site, RO-76 interacted with the sodium site residues through a water in cryo-EM of RO-76 bound to MOR-Gi complex. Previous high-resolution structures of MOR have predicted the presence of a polar cavity in the sodium binding pocket, but these waters have not been rationally targeted before at MOR or other GPCRs to the best of our knowledge. In mice, the drug was systemically active in tail withdrawal assays, and showed reduced respiratory depression and conditioned place preference compared to morphine. In summary, we envision that targeting the sodium binding site may be a potential avenue to both probe the role of the sodium site in MOR function as well as development of a new class of analgesics in the near future. Support and sponsors: Center for Clinical Pharmacology University of Health Sciences and Pharmacy at St. Louis National Institute of Drug Abuse
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 538
Open AccessStructure based approaches on fentanyl template to design novel mu opioid modulators
ID 52769 Poster Board 538 Opioids are used for the treatment of acute to severe pain. Usage of opioids also produces liabilities like respiratory depression and addiction, which in combination with illicit use of fentanyl and designer analogs has contributed to the opioid epidemic. Most approaches to design safer opioids have been restricted to targeting the orthosteric binding sites. We have recently reported a novel strategy to design functionally selective opioids by targeting the sodium binding allosteric site in the mu opioid receptor (MOR). The lead ligand C6 guano engages a key residue Asp2.50 in the sodium site through a salt bridge with a guanidine group in the ligand. C6 guano shows MOR dependent antinociception with reduced adverse effects seen with clinically used opioids (Faouzi et al., Nature 2023, 613, 767–774). While representing a significant advance in the design of opioids, C6 guano is supraspinally active because of the polar and charged guanidine group. Using the cryo-EM structure of C6 guano bound to MOR, we designed second generation analogs to optimize the systemic activity of C6 guano. Characterization of analogs led to the identification of a fentanyl-derived compound named RO-76 which in TRUPATH assays showed reduced efficacy at all Gi/o/z subtypes and no measurable efficacy at β-arrestin-1/2 and labelled unique transducers in APEX2 proximity labeling assays. Unlike C6 guano which showed direct engagement of the sodium site, RO-76 interacted with the sodium site residues through a water in cryo-EM of RO-76 bound to MOR-Gi complex. Previous high-resolution structures of MOR have predicted the presence of a polar cavity in the sodium binding pocket, but these waters have not been rationally targeted before at MOR or other GPCRs to the best of our knowledge. In mice, the drug was systemically active in tail withdrawal assays, and showed reduced respiratory depression and conditioned place preference compared to morphine. In summary, we envision that targeting the sodium binding site may be a potential avenue to both probe the role of the sodium site in MOR function as well as development of a new class of analgesics in the near future. Support and sponsors: Center for Clinical Pharmacology University of Health Sciences and Pharmacy at St. Louis National Institute of Drug Abuse
- 24 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (621) , eabk1533
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
Sequential immunization elicits antibodies against the V3-glycan patch of HIV-1 Env in rhesus macaques and also induces off-target antibody responses.
- 24 November 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (621) , eabk1533
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
Sequential immunization elicits antibodies against the V3-glycan patch of HIV-1 Env in rhesus macaques and also induces off-target antibody responses.
- Open Access
- 4 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0247963
Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
Current influenza vaccines do not elicit broadly protective immune responses against multiple strains. New strategies to focus the humoral immune response to conserved regions on influenza antigens are therefore required for recognition by broadly neutralizing antibodies. It has been suggested that B-cells with receptors that recognize conserved epitopes would be preferentially stimulated through avidity effects by mosaic particles presenting multiple forms of a variable antigen. We adapted SpyCatcher-based platforms, AP205 virus-like particles (VLPs) and mi3 nanoparticles (NPs), to covalently co-display SpyTagged hemagglutinin (HA) trimers from group 1 and group 2 influenza A strains. Here we show successful homotypic and heterotypic conjugation of up to 8 different HA trimers to both VLPs and NPs. We characterized the HA-VLPs and HA-NPs by cryo-electron tomography to derive the average number of conjugated HAs and their separation distances on particles, and compared immunizations of mosaic and homotypic particles in wild-type mice. Both types of HA particles elicited strong antibody responses, but the mosaic particles did not consistently elicit broader immune responses than mixtures of homotypic particles. We conclude that covalent attachment of HAs from currently-circulating influenza strains represents a viable alternative to current annual influenza vaccine strategies, but in the absence of further modifications, is unlikely to represent a method for making a universal influenza vaccine.
- 4 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0247963
Open AccessConstruction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers
Current influenza vaccines do not elicit broadly protective immune responses against multiple strains. New strategies to focus the humoral immune response to conserved regions on influenza antigens are therefore required for recognition by broadly neutralizing antibodies. It has been suggested that B-cells with receptors that recognize conserved epitopes would be preferentially stimulated through avidity effects by mosaic particles presenting multiple forms of a variable antigen. We adapted SpyCatcher-based platforms, AP205 virus-like particles (VLPs) and mi3 nanoparticles (NPs), to covalently co-display SpyTagged hemagglutinin (HA) trimers from group 1 and group 2 influenza A strains. Here we show successful homotypic and heterotypic conjugation of up to 8 different HA trimers to both VLPs and NPs. We characterized the HA-VLPs and HA-NPs by cryo-electron tomography to derive the average number of conjugated HAs and their separation distances on particles, and compared immunizations of mosaic and homotypic particles in wild-type mice. Both types of HA particles elicited strong antibody responses, but the mosaic particles did not consistently elicit broader immune responses than mixtures of homotypic particles. We conclude that covalent attachment of HAs from currently-circulating influenza strains represents a viable alternative to current annual influenza vaccine strategies, but in the absence of further modifications, is unlikely to represent a method for making a universal influenza vaccine.
- Open Access
- 1 October 2018
- Published by Elsevier in Cell Host & Microbe
- Vol. 24 (4) , 579-592.e4
Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
- 1 October 2018
- Published by Elsevier in Cell Host & Microbe
- Vol. 24 (4) , 579-592.e4
Open AccessPartially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
- Open Access
- 26 May 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The prefusion Env trimer is stabilized by V1V2 loops that interact at the trimer apex. Broadly neutralizing antibodies (bNAbs) against V1V2 loops, exemplified by PG9, bind asymmetrically as a single Fab to the apex of the symmetric Env trimer using a protruding CDRH3 to penetrate the Env glycan shield. Here we characterized a distinct mode of V1V2 epitope recognition by the new bNAb BG1 in which two Fabs bind asymmetrically per Env trimer using a compact CDRH3. Comparisons between cryo-EM structures of Env trimer complexed with BG1 (6.2 Å resolution) and PG9 (11.5 Å resolution) revealed a new V1V2-targeting strategy by BG1. Analyses of the EM structures provided information relevant to vaccine design including molecular details for different modes of asymmetric recognition of Env trimer and a binding model for BG1 recognition of V1V2 involving glycan flexibility.
- 26 May 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Open AccessAsymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies
The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The prefusion Env trimer is stabilized by V1V2 loops that interact at the trimer apex. Broadly neutralizing antibodies (bNAbs) against V1V2 loops, exemplified by PG9, bind asymmetrically as a single Fab to the apex of the symmetric Env trimer using a protruding CDRH3 to penetrate the Env glycan shield. Here we characterized a distinct mode of V1V2 epitope recognition by the new bNAb BG1 in which two Fabs bind asymmetrically per Env trimer using a compact CDRH3. Comparisons between cryo-EM structures of Env trimer complexed with BG1 (6.2 Å resolution) and PG9 (11.5 Å resolution) revealed a new V1V2-targeting strategy by BG1. Analyses of the EM structures provided information relevant to vaccine design including molecular details for different modes of asymmetric recognition of Env trimer and a binding model for BG1 recognition of V1V2 involving glycan flexibility.